CP-1414S

CP-1414S is an experimental drug first made by a team in Germany.[1] It is a benzodiazepine derivative. CP-1414S is a 1,5-benzodiazepine, with the nitrogen atoms located at positions 1 and 5 of the diazepine ring, and so is most closely related to other 1,5-benzodiazepines such as clobazam.

CP-1414S

Clinical data
ATC code	none
Identifiers
IUPAC name 1-phenyl-4-amino-8-nitro-3H-1,5-benzodiazepin-2-one
CAS Number	36975-99-2
PubChem CID	37594
ChemSpider	34483
CompTox Dashboard (EPA)	DTXSID50958148
Chemical and physical data
Formula	C15H12N4O3
Molar mass	296.286 g·mol^−1
InChI InChI=1S/C15H12N4O3/c16-14-9-15(20)18(10-4-2-1-3-5-10)13-8-11(19(21)22)6-7-12(13)17-14/h1-8H,9H2,(H2,16,17) Key:MBSVPZTUXNRICW-UHFFFAOYSA-N
(verify)

CP-1414S has primarily anxiolytic and anticonvulsant effects.[2] Its potency is roughly equal to that of clobazam, but with more pronounced sedation.[3]

See also

• Benzodiazepine

References

1. US Patent 3766169 PROCESS FOR THE PREPARATION OF 3-AMINOMETHYLIDENE-1,5-BENZODIAZEPINE-2,4-(3H,5H)-DIONES
2. Carli M, Ballabio M, Caccia S, Garattini S, Samanin R (1981). "Studies on some pharmacological activities of 7-nitro-2-amino-5-phenyl-3H-1,5-benzodiazepine (CP 1414 S) in the rat. A comparison with diazepam". Arzneimittel-Forschung. 31 (10): 1721–3. PMID 6119091.
3. Mennini T, Garattini S (November 1982). "Benzodiazepine receptors': correlation with pharmacological responses in living animals". Life Sciences. 31 (19): 2025–35. doi:10.1016/0024-3205(82)90094-7. PMID 6129557.